Research Study

The SARTAN-AD Trial: A Randomized, Open Label, Proof of Concept Study of Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients
Principal Investigator 
Ging-Yuek Robin Hsiung

Overview

Body Locations and Systems 
Disorders and Conditions 
Alzheimer's Disease
ClinicalTrials.gov# 
NCT02085265
Status 
Recruiting
Study Start/End 
Feb 22, 2016 to Jan 1, 2019
Locations 
UBC Hospital
Name/Title 
Boris Feldman, Research Associate
Phone 
604-822-9417
Email Address 
boris.feldman@vch.ca
Purpose of Study 

The purpose of this project is to conduct a proof of concept study in patients with probable Alzheimer's Disease who have mild to moderate hypertension, in order to determine if there is less global brain atrophy over one year, as measured by ventricular enlargement as a primary outcome measure, when patients are randomized to treatment with an angiotensin receptor blocker compared to an Angiotensin Converting Enzyme inhibitor (ACEI).

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.